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Abstract 
 
TWO METHODS TO DETECT CLONAL POPULATIONS OF HUMAN CELLS 
IN SITU. Philip Hall, Jonathan Murphy, and Jeffrey Sklar, Department of Pathology, 
Yale University, School of Medicine, New Haven, CT.    
A molecular assay to detect clonal populations of human cells in situ would be 
potentially valuable for both investigational and diagnostic purposes.  Two such 
methods are proposed, both utilizing fluorescence in situ hybridization (FISH).   The 
first relies upon random monoallelic expression of genes (so-called allelic exclusion), 
in which a subset of human genes are normally expressed at a single allele in a fixed 
fraction of cells within a tissue, independent of the parental origin of the allele.  It is 
hypothesized that application of FISH to assess the allelic expression patterns among 
one or more of these genes should be able to distinguish a monoclonal population of 
cells from a polyclonal one.  The second method, specific for T-cells, relies upon 
VDJ segmental recombination at the T-cell receptor beta locus.   With this method, 
our hypothesis is that analysis by FISH of the configuration of rearranged VDJ 
segments should be able to distinguish a monoclonal population of T cells from a 
polyclonal population.  Both proposed assays were tested on benign tonsil and 
thymus tissue as well as on monoclonal cell pellets produced from neoplastic cell 
lines.  In those analyses that could be completed, attempts to assess the expression 
pattern either of genes subject to random allelic exclusion or the determination of 
VDJ segmental recombination failed to distinguish monoclonality from polyclonality.   
Although unsuccessful, the failure of these attempts was due to technical limitations 
and not to fundamental problems with the underlying hypotheses. 
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Introduction 
 
The ability to determine whether a population of human cells is clonal, its 
lineage traceable to the division of a single cell, has been valuable for various types of 
basic biologic studies and for certain diagnostic applications.   An important area for 
which considerations of clonality are relevant is neoplasia and cancer.  Most, if not all 
neoplasms arise from the clonal proliferation of cells derived from a single 
transformed precursor cell (1-6).  Moreover, the identification of multiple different 
types of preneoplastic or premalignant lesions has motivated the investigation of their 
clonality, especially in connection to the risk of potential transformation to true 
neoplasia. Indeed, several molecular methods now in widespread use for the 
diagnosis and detection of some human cancers rely upon the identification of a 
monoclonal population of cells (4, 7-9).  These methods have all involved extraction 
of nucleic acids from cells that have been removed from tissues and are not broadly 
applicable to all cell types.  In this thesis, we propose two methods of expanding the 
applicability of assays for monoclonality, notably using in situ techniques that 
preserve cell and tissue morphology, with a discussion of initial experience with these 
methods.   
The difficulty of creating an assay for clonality derives from the fact that 
neoplastic cells share most of the same genetic makeup as non-neoplastic cells and 
display many of the same proteins.  For those specific differences that occur, 
distinguishing neoplastic from normal, polyclonal cells by their genetic or protein 
composition alone requires prior knowledge of, or an extensive, often expensive 
search for how the two populations differ (1, 6, 10-11).   In this manner, identifying 
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one or more genetic variants--such as a specific point mutation, as occurs frequently 
in neoplasia; a DNA deletion, as is associated with tumor suppressor genes; or a 
chromosomal translocation, as is found in several hematologic malignancies and 
sarcomas--has been beneficial not only for advancing our understanding of 
carcinogenesis but also for improving our ability to diagnose malignancy (6, 11).  
Unfortunately, for most cancers, a defining genetic variation either is not known, is 
present in only a fraction of cases of a given cancer, or is not a convenient marker for 
technical reasons (e.g., mutations that might occur anywhere over large regions of 
DNA within an oncogene).  On these grounds, a generic, broadly applicable test for 
clonality would be of great diagnostic utility.   
In the absence of a broadly applicable, objective test for clonality, current 
methods of diagnosing cancer continue to rely on the evaluation of morphologic and 
histopathologic features, which are subject to interobserver variability (12, 13).  
Nevertheless, because of the many decades of experience with the histopathology of 
tumors, much information has been accumulated about the histopathologic 
characteristics of neoplasms, and morphology-based diagnostic criteria have been 
established.  A reliable and convenient method of detecting clonality would be 
valuable to both researchers and diagnosticians, particularly if clonality could be 
assessed in situ and directly correlated with morphology. 
There have been several proposed assays to determine the clonality of a 
population of human cells, but each has been hampered by limitations related to 
specific tissues or to technical problems that restrict its use.   Very few offer the 
potential for in situ analysis.  The assays that can be applied to detect monoclonality 
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in more than one or a few specific tumor types have relied upon the determination of 
one of a small number of genetic events that are known to occur randomly during the 
differentiation of certain somatic cells.  The guiding principle of such assays is that 
certain genetic or epigenetic events, whether dichotomous, as in the choice of a kappa 
or lambda light chain immunoglobulin gene for expression in B lymphocytes; or 
polychotomous, as in T-cell receptor or immunoglobulin gene rearrangement 
patterns, occur randomly in a polyclonal population of human cells; i.e., each cell in 
the population is (or is descended from) a cell in which the genetic or epigenetic 
event has occurred and has resulted in a fixed change (kappa expression vs. lambda, 
or a particular VDJ rearrangement) (4, 6-7, 9, 14-31).  A monoclonal population, 
however, will display a decidedly, or statistically, non-random pattern, if the genetic 
or epigenetic event occurred prior to the clonal expansion of that particular cell 
population.  As an example, the ratio of B lymphocytes making kappa to B 
lymphocytes making lambda light chains, within a given population of non-neoplastic 
cells, should fall within a statistically predictable range centered around 2:1.  
Deviation from that range is evidence of the presence of a clonal population (6).  
Similarly, the configuration of rearranged V, D, and J segments that have been joined 
together in the immunoglobulin heavy chain loci of genomic DNA (as well as the 
precise sequence of DNA at the junction of these segments and the length of that 
sequence) differs among different mature B lymphocytes.  Gel electrophoresis of the 
products generated from the cellular DNA of a polyclonal population of B 
lymphocytes by the polymerase chain reaction (PCR) using primers that flank the 
VDJ junctions within the immunoglobulin heavy chain locus results in a smear of 
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similarly sized but diverse bands that differ in their precise lengths.  In contrast, the 
finding of a discrete band by gel electrophoresis is indicative of the presence of a 
monoclonal population, i.e., that a significant fraction of the cells have an identical 
VDJ rearrangement, implying that those cells are all derived from a single precursor 
cell in which that particular VDJ rearrangement occurred (4, 8-10, 30, 32).   Both of 
these examples, where specific, non-random events distinguish monoclonal from 
polyclonal cell populations, in which comparable events are random, have been used 
by clinicians to aid in the diagnosis of malignancy, notably lymphocytic cancers (2, 4, 
7-9, 30, 33, 34).  As illustrated by these examples, PCR, along with flow cytometry 
and immunohistochemistry, remain the diagnostic tools of choice for many 
lymphoproliferative disorders (35).  However, these examples are limited to 
lymphocytes, the only cells known to undergo somatic recombination in a specific 
genetic locus during normal maturation and differentiation or to produce kappa or 
lambda light chains.   
An assay for clonality must target a genetic or epigenetic event that occurs in 
the type of cell from which the neoplasm (or clone) arises.  Thus, the most useful 
genetic/epigenetic event would be one that occurs in all somatic cells.  An assay 
widely used in basic biologic studies has focused on X-chromosome inactivation, a 
random dichotomous event that occurs in female somatic cells during early 
embryologic development, whereby in each cell, either the maternally- or paternally-
derived X-chromosome is inactivated, with stable transmission of the inactivated state 
to the same X chromosome in all of that cell’s progeny (1, 6, 36).  Assays that can 
distinguish whether the active X-chromosome in a female somatic cell is paternally- 
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or maternally-derived allow for clonal analysis of a population of human cells.  
Evidence for preponderance of inactivation of one or the other X-chromosome 
homologs is consistent with a monoclonal population of cells.  However, such 
assessments depend in part on the characteristics of the background cell population 
and the ratio between activation of the two X-chromosomes in the particular tissue in 
which a population of cells is being analyzed, since skewing from the theoretical 1:1 
ratio is sometimes observed in normal tissues.   Initial attempts to distinguish the 
active X-chromosome relied on the analysis of gene products in female individuals 
heterozygous for a gene on the X-chromosome, commonly glucose-6-phosphate 
dehydrogenase (1, 3).  While successful, these analyses were limited by the relative 
rarity of individuals heterozygous for those particular polymorphisms (3).  Later 
analyses were based on the fact that DNA of the inactive X-chromosome is 
hypermethylated relative to the active X-chromosome.  To distinguish the active from 
inactive X-chromosome DNA, the DNA extracted from the tissue sample was cleaved 
using methylation-sensitive endonucleases, followed by Southern blot hybridization, 
or, alternatively, DNA of a gene on the X-chromosome, typically the PGK or 
androgen receptor gene, was amplified using PCR, followed by analysis of the 
products by gel electrophoresis.  In either of these strategies, X-chromosome loci 
were selected for analysis based on highly prevalent polymorphisms in DNA 
sequence that could be detected either by restriction fragment length polymorphism 
(RFLP) in Southern blot analysis or differently-sized PCR products (3, 5, 10, 37).  
Such polymorphism analysis enabled distinction of the two X-chromosomes within 
female tissues and permitted analysis of a larger percentage of females than were 
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heterozygous for G6PD.  However, even using these methods, it was still possible to 
accomplish analysis in only a fraction of cases.  For example, in one study, only 
thirteen of the fifteen tissue samples could be analyzed, either due to skewing in the 
normal surrounding tissues or, less frequently, to lack of heterozygosity in the locus 
used for analysis (3).    
In addition to other technical limitations, the above strategies for analysis of 
clonality have been limited either to lymphocytes or to female somatic cells.  Other 
strategies have been employed in particular settings.  For example, variations in the 
stucture of Epstein-Barr virus (EBV) episomal DNA has been used as a clonal 
marker.  Each cell infected with EBV has multiple identical circular episomes of viral 
DNA, formed by covalent ligation of the two ends of the double-stranded, linear 
genome upon cellular infection.  Both ends of the linear genome are composed of the 
same tandem repeat sequences, about 500 basepairs in length, and the episomal form 
of the EBV genome in latently infected cells is generated by homologous 
recombination between the tandem repeats leaving variable numbers of such repeats 
in the episomal circles.  The number of included repeats is stable and is passed on by 
precursor cells to their progeny without variation (6, 38).  Analyzing the length of the 
region containing the repeats by Southern blot has helped identify clonality within 
several tumors, including nasopharyngeal carcinoma and Hodgkin’s disease, but is 
obviously limited to EBV-infected cells (6, 38, 39).  Other techniques have analyzed 
sites of integration into host cell DNA by Hepatitis B viral DNA, as a unique marker 
of an infected cell and its progeny.   As with EBV, this marker is limited to only 
specific situations, such as hepatocellular carcinoma (6, 40). 
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The clonality assays already described have increased our understanding of 
carcinogenesis and enabled clonal analysis of multiple tumor types and preneoplastic 
processes.  However, these assays have generally not been used routinely for 
diagnosis because of the difficulties or complexities of the technique or the lack of 
broad applicability to many tumor types (37, 41, 42).  An ideal assay, then, would 
need to target a genetic event that occurs randomly within a given population of cells, 
one that occurs in multiple or most cell types and populations, one that produces 
some heritable, cellular change that is not affected by growth conditions or by 
neoplastic transformation, and one that can be easily assessed.  Random monoallelic 
gene expression, also referred to as allelic exclusion, may provide exactly such an 
event, especially in light of the multiple recent advances in our understanding both of 
the process itself and of its prevalence within cells. 
Monoallelic expression occurs when one of two alleles for a specific gene is 
activate and the other is inactive, such that only one of the two alleles is transcribed.  
This situation may arise through the random activation of one allele while the other 
allele remains inactive, or, conversely, through the random inactivation of one allele 
of a gene in which both alleles are initially active.  On a chromosome-wide basis, a 
similar process gives rise to random X-chromosome inactivation in female somatic 
cells.   So-called imprinting of autosomal genes also involves inactivation of only one 
allele in somatic cells, but differs fundamentally from random monoallelic expression 
because either the paternally- or maternally-inherited copy of an imprinted gene is 
consistently inactivated (36, 43-45).  Imprinted genes have been implicated in several 
inherited human diseases, the best known being Prader-Willi and Angelman 
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Syndrome, which are both due to deletion of the same chromosomal region (15q11-
13) but differ phenotypically depending upon the parental origin of the chromosome 
that suffers the deletion (43, 44, 46).   
A third type of monoallelic expression involves random transcriptional 
inactivation of a single allele in cells in which both alleles are initially active; in this 
type of monoallelic expression, the choice of which allele is expressed is independent 
of its parental origin (47-52).  In fact, it seems that random monoallelic expression of 
a given gene often occurs in only a minority of the cells within a tissue in which that 
gene is active, but it appears to be a stable percentage (50).  In 1994, Chess et al. 
described random monoallelic expression of olfactory receptor genes in sensory 
neurons, and in 2007, Gimelbrant et al. analyzed 4,000 somatic human genes in 
clonal cell lines and identified 300 as demonstrating random monoallelic expression 
(48, 50).  The expression patterns indicated that monoallelic expression was 
frequently present in a consistent minority of cells regardless of the specific tissue 
from which the cells were derived.  
Compared to the markers for clonality so far described, random monoallelic 
expression has several theoretical advantages.  It occurs in genes on multiple 
autosomal chromosomes, making it usable in both male and female cells.  For several 
genes identified in the Gimelbrant study, evidence was provided that random 
monoallelic expression was present in multiple tissue types in a measurable and 
consistent percentage of cells within each tissue type, but not in all cells.  Finally, 
random monoallelic gene expression is observed in a significant minority of 
expressed genes, each of which could be a promising target for a clonality assay 
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depending upon the particular tissue and the extent to which that gene is expressed in 
a monoallelic fashion within that tissue (i.e., the fraction of cells that exhibit 
monoallelic expression).    
The difficulty in creating an assay for clonality arises in creating a molecular 
technique to identify the pattern of monoallelic expression within a population of 
cells.  The necessary and important assumption, to be confirmed or rejected in this 
and future studies, is that the pattern of random monoallelic expression is passed from 
progenitor cells to their progeny in a stable fashion.  However, as stated above, X-
chromosome inactivation is the biologic process most analogous to random 
monoallelic gene expression and the stability of inactivation in that process is well 
known. Given the success of assays targeting X-chromosome inactivation, random 
allelic inactivation would seem a promising target for investigation for this 
experiment.   Although it would be possible to use a similar technique to that used in 
X-chromosome inactivation, namely the analysis of polymorphisms within a gene 
subject to random monoallelic expression, the limited association of suitable and 
predictable polymorphisms within appropriate genes greatly complicates this 
approach.  But even more importantly, random allelic inactivation occurs in only a 
percentage of cells, instead of in every cell as with X-chromosome inactivation.  
Upon initial consideration, this observation presents a difficult challenge for 
distinguishing a monoclonal population of cells from a polyclonal population based 
on patterns of allelic expression, at least if an approach similar to that used for 
assessing X-chromosome inactivation were employed.  However, this feature of 
monoallelic gene expression in subtotal fractions of cell populations within tissues 
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actually offers a special opportunity for its use as a marker for in situ detection of 
clonality.    
Despite the advantages of in situ assays for the determination of 
monoclonality in preneoplastic or neoplastic tissues in histologic sections, very few 
such assays currently exist.  The one in situ clonality assay widely used at present in 
clinical settings has employed antibody staining for kappa and lambda 
immunoglobulin light chains (6).   Besides being limited to B cells, this method has 
various disadvantages, principally problems involving its application to formalin-
fixed, paraffin-embedded tissues - the standard material from which histologic 
sections are prepared.  In situ hybridization for kappa and lambda immunoglobulin 
light chain mRNA has also been utilized (53), but this approach is generally 
considered too difficult for routine clinical use.  In 2001, Nuovo et al. described the 
use of reverse transcriptase in situ PCR to detect T-cell-receptor beta rearrangements 
in T cell populations, which enabled them to distinguish clonal T cell populations in 
lymphomas from polyclonal populations in reactive lymph nodes (54).  However, this 
method has significant drawbacks that hinder its clinical adoption, notably its 
requirement for multiple tissue sections and sequential experimental repetitions to 
distinguish among different V segments using the twenty-five forward primers 
necessary to detect the uniquely expressed TCR-beta rearrangements.   Furthermore, 
in situ PCR is a very problematic technique that is not in general use because of 
limited reproducibility.   
On the other hand, in situ genetic examination has been greatly augmented by 
advances in fluorescence in situ hybridization (FISH) (27, 55-57).  FISH has been 
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widely adopted clinically in the diagnosis and characterization of many malignancies, 
largely based upon its ability to detect genetic translocations, deletions, and other 
chromosomal abnormalities (56, 58).  All of these applications involve hybridization 
to DNA targets.   Additionally, a simple modification of DNA FISH--RNA FISH, 
which targets RNA sequences--has enabled the study of gene expression by 
identifying sites of RNA transcription at the cellular level (43, 57, 59-66).  
Importantly, the technology can be used with formalin-fixed, paraffin-embedded 
tissue, rendering it promising for pathologic research and clinical diagnosis (67).    In 
the Gimelbrant study, the use of RNA FISH was coupled with DNA FISH to confirm 
monoallelic or biallelic expression of two sample genes, death-associated protein 
kinase 1 (DAPK1) and early B cell factor (EBF), in peripheral blood monocytes 
(PBMCs) and clonal lymphoblast lines (50).  In this study, 36% and 38% of PBMCs 
showed monoallelic expression for the two genes, respectively, and in the clonal 
lymphoblast lines known to display monoallelic expression of one or both genes, 97% 
and 98% showed monoallelic expression with FISH.  However, only 77% and 78% of 
cells from clonal lymphoblast lines known to have biallelic expression of the two 
genes displayed biallelic expression with FISH.   The reasons for this seem likely to 
be technical.   
Despite the reduced sensitivity of combined RNA and DNA FISH for 
detecting biallelic expression, use of these methods still seems to offer a promising 
method for clonality analysis.  If RNA and DNA FISH were used to assay whether 
one or both alleles for a given gene are expressed in a collection of human cells, the 
ratio of monoallelic to biallelic expression should fall within a statistically predictable 
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ratio, depending upon the gene chosen for analysis, the tissue in question, and the 
sensitivity of the assay.   To increase the sensitivity of the assay, it should also be 
possible to investigate the expression patterns of multiple genes simultaneously with 
probes tagged with multiple fluorophors to distinguish the different genes.  This is the 
strategy we chose for our studies.   
We began by selecting two genes for analysis, based upon their expression 
and prevalence of random monoallelic inactivation in many tissues.  These genes 
were in fact the same two used for FISH analysis in the Gimelbrant study: DAPK1, on 
chromosome 9q34, and early B cell factor (EBF), on chromosome 5q34 (50).  We 
then designed a fluorescent probe for hybridization to intronic sequences of these 
genes. The same probe was selected for both RNA and DNA FISH, with the method 
of hybridization distinguishing between the RNA and DNA targets.  For each gene, 
DNA FISH serves as an internal control, as it should identify two alleles in each cell. 
RNA FISH tests whether transcription is monoallelic or biallelic, based on the 
presence or absence of a nascent, unspliced mRNA (59, 60, 65).  The use of an 
intronic probe assures that only nascent mRNA will be visualized, since mature 
mRNA lacks the introns to which the probe is designed to hybridize.  Because 
splicing of exons occurs soon after transcription, or perhaps even co-transcriptionally, 
nascent, precursor mRNA is localized near or at the site of transcription, close to the 
gene encoding that mRNA.  
While the published data forming the rationale and methodologic bases for 
these studies for in situ assessment of clonality seemed fairly strong, we also decided 
to pursue a parallel, more limited but still potentially useful approach to the in situ 
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assessment of clonality for clinical purposes. This approach also involved FISH and 
was directed at assessment of the clonality of T cells.  As described above, Nuovo et 
al. used RT in situ PCR for their assay because FISH was thought to be too 
insensitive at the time to identify the short regions of DNA involved in TCR beta 
recombination and because of the need to use multiple probes on several tissue 
sections to distinguish among the myriad possible combinations of variable (V), 
diversity (D), or joining (J) segments (54).  However, we decided to attempt an 
approach markedly different from that of Nuovo, et al. by utilizing FISH directed at a 
specific region in the TCR beta gene and a statistical feature of TCR beta gene 
rearrangement that characterizes the TCR beta gene in normal T lymphocytes.    
 In a review of T cell development published in 1992, Malissen et al. 
discussed the frequency of various configurations of TCR beta gene rearrangements 
among T cells.  Within developing T cells, both alleles undergo D-J joining, but 
whether or not only one or both alleles undergo subsequent V-DJ joining depends 
upon the outcome of first V-DJ rearrangement with respect to production of a 
functional protein product.  If rearrangement in that first allele is successful, the 
second allele does not undergo rearrangement (68).   Great diversity in the sequence 
of DNA across the VDJ junction occurs among fully rearranged alleles due to the 
combined effects of exonucleolytic digestion removing varying numbers of basepairs 
at the ends of recombining segments plus the addition of variable numbers of random 
basepairs at the ends of the segments by the enzyme terminal transferase prior to 
ligation of V, D, and J segments.  Non-functional VDJ rearrangements are relatively 
common, since two-thirds of the sequences generated at the VDJ junctions will be out 
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of frame in the J and C (constant region) coding sequences.  Malissen et al. predicted 
accordingly a two-thirds failure rate for the first allelic rearrangement and a two-
thirds failure rate for the second allelic rearrangement.  As a viable T cell needs at 
least one successful V-DJ rearrangement of the TCR beta allele, the ratio of cells with 
one rearranged locus and one non-rearranged locus to those with two rearranged loci 
should be about 3:2, as summarized in Figure 4 of their paper.  In an analysis of ten T 
cell clones, they found a ratio of 5:5, with one clone interestingly possessing two 
successful V-DJ recombinations.   
Although their experiment was done in murine T cells and we could find no 
analogous analysis of human T cells, we thought that while the ratio might be 
somewhat different in human T cells, the principle should still allow us to distinguish 
a polyclonal population with a mix of biallelic and monoallelic recombination 
patterns from a monoclonal population with a predominance of one or the other 
pattern.   
To distinguish the recombination patterns in situ, we developed FISH probes 
targeting the 64kb region of DNA between V29-1, the second-most 3’ variable region 
of the TCR beta locus on chromosome 7, and D1, the most 5’ diversity region (69).  
An additional, rarely used variable region, V30, is located 3’ of the C region (69).  
Control probes were developed targeting the DNA regions immediately 5’ and 3’ of 
the TCR beta locus, so as not to be involved in genetic recombination.  As successful 
V-DJ recombination involving any of the variable regions other than V30 causes the 
excision and rapid destruction of the 64kb region of the TCR beta locus, DNA FISH 
performed with probes for this test region should be able to distinguish a monoclonal 
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population of T cells from a polyclonal population (70).   Specifically, in a polyclonal 
population, every cell should display the control probe signal on both alleles, but 
there should be a mix of cells with one allele having only D-J recombination, and 
therefore one test probe signal, and cells with both alleles having V-DJ 
recombination, and no test probe signals.  A monoclonal population should have one 
type of cells or the other.  In an actual tissue sample containing a monoclonal sample, 
there are still always polyclonal T cells and non-lymphoid cells intermixed with 
monoclonal T cells, and in this situation, there should be a preponderance of cells 
with either one test probe signal or no test probe signal.   
In situ clonality assays, for which random monoallelic gene expression and 
genetic recombination within TCR genes represent two distinct and promising 
approaches, have the potential to add to our understanding of carcinogenesis and 
facilitate clinical diagnosis of malignancy.  Random monoallelic gene expression, if it 
turns out to be a successful target, could be used in a variety of tissue and tumor 
types.   Further research will continue to characterize the large variety of human 
genes known to be subject to random monoallelic expression and the extent to which 
this occurs in various tissue types.   Genetic recombination within the T cell receptor 
beta locus may be a technically easier assay, requiring DNA FISH alone without the 
need for RNA FISH, but as described in this thesis, it is limited to the study of T cell 
proliferations.  Nevertheless, if the principle works for T cells, it should be possible to 
develop an analogous test for B cells through analysis of recombination within the 
immunoglobulin heavy chain locus.     
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Statement of Purpose 
The aim of this thesis is to describe and develop two methods of in situ analysis of the 
clonality of populations of human cells, both of which rely upon fluorescence in situ 
hybridization (FISH).   In the first method, a combination of DNA FISH and RNA 
FISH will be used to characterize the expression patterns in lymphoid tissues of two 
genes which are known to be subject to random monoallelic gene expression.   In the 
second method, DNA FISH will be used to characterize the genetic recombination 
patterns of the T cell receptor beta locus in T cells.  Our hypothesis is that both of 
these methods should be able to distinguish statistically a monoclonal population of 
cells from a polyclonal population within tissue sections on a microscope slide.   
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Methods 
Probe Generation: 
DAPK1 and EBF probes: DNA and RNA FISH probes were generated using an 
adaptation of the method used by Gimelbrant et al., chosen because of their 
successful use for both DNA and RNA FISH in that paper (50).  BAC clones were 
obtained from the BACPAC Resource Center, available at bacpac.chori.org, 
containing between 200-400 kb of the two genes in question.  The great majority of 
DNA within these BACs consists of introns but some exon sequence is included.  For 
DAPK1, the clone RP11-107G16 was obtained, and for EBF, RP11-155P16.  These 
were the same BAC clones used by Gimelbrant et al.  To amplify BAC DNA, the 
clones in E. coli were incubated in LB media containing 12.5 (m)g/ml 
chloramphenicol.  DNA was isolated from 5ml bacterial cultures using the Qiagen 
QiaPrep Spin Miniprep kit, eluated from the spin column with 50 (m)l of Qiagen 
elution buffer (EB) in the final step.   
For verification that the BAC DNA contained the appropriate genetic 
sequences of DAPK1 or EBF, PCR was performed using primers chosen from the 
NCBI sequences for both genes (www.ncbi.nlm.nih.gov/gene) using MacVector 
software.  For DAPK1, the primers chosen were TCTGTGTCCATCCCCCCGAT, 
forward, and CCATCTATTCCCTTTCCTTTCCGT, reverse, both presented in 5’ to 
3’ direction.  These primers are complementary to DNA sequences approximately 3.5 
kb apart, within an intron of DAPK1 according to the NCBI database, and were 
chosen to be that far apart in case they might be used for generation of FISH probe 
instead of BAC clone verification.  For EBF, the primers chosen were 
  
21 
TTCTCTCTCTTGGCTAAGCGG, forward, and CAATGAGCGGAAAAGCGAGG, 
reverse, also presented 5’ to 3’.  These primers are complementary to DNA sequences 
approximately 3.3 kb apart within an intron of EBF, according to the NCBI database.   
Verification PCR was performed as follows: 17.3 µl H2O, 1 µl forward primer, 1 µl 
reverse primer, 2 µl clone DNA or H20 for control, 0.5 µl Mg2+ 50x buffer, 0.5 µl 
50x dNTP mix, 0.2 µl Taq polymerase, were mixed and subjected to 35 cycles of 
PCR at a 64˚C annealing temperature.  The PCR products were separated by 1% 
agarose gel electrophoresis at 120 mV for 30 minutes, with the results shown in 
Figure 1. 
 
TCR beta probes:  In a similar manner, BAC clones were selected containing regions 
of the TCR beta (TCRB) locus.  According to the NCBI sequence, there is a 64 kb 
region between V29-1 and D1, as referred to above.  Comparing the NCBI Clone 
Registry and Map Viewer (available at 
www.ncbi.nlm.nih.gov/projects/genome/clone/) with the sequence map of TCRB, the 
BAC CTD-3217E23 was found to contain a 16kb region within the target 64 kb.  This 
BAC was acquired from Invitrogen (clones.invitrogen.com), and is abbreviated VDR, 
for V-D region.  The BAC RP11-368I15 was obtained from the BACPAC Resource 
Center containing a 250 kb region 3’ to the TCRB locus for use as a control, here 
abbreviated 3CR, for 3’ control region.  This clone had been used by Soulier et al. in 
an experiment using DNA FISH to identify the TCRB locus (71).  An additional 
BAC, RP11-10L5 acquired from the BACPAC Resource Center contains 
approximately 250kb of DNA 5’ to the TCRB locus as an additional control, and is 
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abbreviated 5CR, for 5’ control region.  Each of these BAC clones in E. coli were 
cultured in LB media containing 12.5 µg/ml chloramphenicol, and the DNA was 
extracted from the bacteria using the Qiagen QiaPrep Spin Miniprep kit as above.  
The clones were verified by PCR to contain the appropriate region of DNA, using the 
same PCR parameters as for DAPK1 and EBF above.  Primers were chosen using the 
MacVector program from the NCBI genetic sequence of TCRB and the surrounding 
DNA regions to be 150-350 bp apart, as follows, all listed 5’ to 3’: 
 
VDR: CCACTAAATGATGTTGTC, forward;  
           TGTGCTCGTTAAGGATTTC, reverse. 
3CR:  TTTGGGGAGCACCCTTTG, forward;  
           CAGGAAGGACAGCTCCT, reverse 
5CR:  GTTAAAACTTACCTCATTAG, forward;  
           GTGTGGCAAACAGACAG, reverse 
 
Gel electrophoresis separation of the PCR products for the TCRB probes with water 
controls (PCR amplification performed without template added) is presented in 
Figure 2.  
 
In subsequent experiments conducted by Jonathan Murphy, an attempt was made to 
increase the amount of signal obtained from the VDR region of the TCRB loci by 
generating twenty-two non-overlapping probes from the VDR using PCR of VDR 
DNA from whole cell DNA.  These probes ranged in size from 2.8 kb to 3.5 kb in 
length, and cumulatively covered approximately 55 kb of the 64 kb region between 
V29-1 and D1.  Together, these probes covered about 39 kb of DNA beyond that 
within the CTD-3217E23 BAC.  (BACs covering the entire 64 kb region are 
available, but all of these contain considerable amounts of DNA outside the 64 kb 
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region, rendering those BACs unsuitable for our purposes; i.e., all DNA 
complementary to the probe is deleted as a result of V-DJ joining within the TCRB 
locus.   
Additionally, twenty-three probes, ranging in size from 3.0 kb to 3.6 kb in 
length, were generated from the 3’ control region.  The PCR to generate the probes 
was performed as follows: 18 µl H2O, 0.25 µl forward primer, 0.25 µl reverse primer, 
1.5 µl clone DNA, 2.0 µl Mg2+, 2.5 µl 10x buffer, 0.5 µl 50x dNTP mix, 0.2 µl Taq 
polymerase, were mixed and subjected to 37 cycles of PCR at a 47.5˚C annealing 
temperature.  The PCR products were separated by 0.7% agarose gel electrophoresis 
and purified from the gel using the Qiagen Gel Purification kit, eluting with 30 ul EB 
buffer (Qiagen). 
 
Probe Labeling: 
Probes were labeled using the Vysis Nick Translation Labeling Kit (Vysis No. 
32-801300, now Abbott 07J00-001) as follows: 17.5 µl Miniprep clone DNA were 
mixed with 5 µl 0.1mM dTTP, 10 µl 0.1 mM dNTP, 5 µl 10x nick translation buffer, 
10 µl nick translation enzyme, and 2.5 µl of dUTP tagged with either 0.2 mM 
Spectrum Red (now Abbott No. 02N34-050) or 0.2 mM Spectrum Green (now Abbott 
No. 02N32-050).  The resulting mixture was vortexed, briefly centrifuged, and 
incubated for fourteen hours at 15˚C, before the nick translation reaction was stopped 
by heating the samples to 70˚C for ten minutes.  At this point, 10 µl of Cot-1 DNA 
(Abbott No. 06J31-001) and 150 µl 100% ethanol were added, the mixture was again 
vortexed and briefly centrifuged before being placed at -80˚C for 30 minutes.  The 
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resulting sample was centrifuged at 4˚C at 12,000 rpm for 30 minutes, the supernatant 
was discarded, and the pellet was resuspended in 20 µl hybridization buffer (500 µl 
formamide, 100 µl 20xSSC, 200 µl dextran sulfate, 200 µl dH2O).  The labeled 
probes were stored at -20˚C until use.  
 
Tissue Preparation: 
Both polyclonal tissue and monoclonal cell lines were used as material for 
FISH analysis with both sets of probes.  Benign human tonsil and thymus tissue, fixed 
in formalin and embedded in paraffin, were obtained from the Molecular Diagnostics 
Service of the Yale Department of Pathology, where these tissues and cells are 
frequently used as controls in their clinical assays.  10 µm-thick sections were cut 
from the paraffin blocks and transferred to slides by the Yale Pathology Tissue 
Services, Research Histology Service.   
The clonal epithelial cell lines HESC (a human endometrial line) and HCT116 
(a human colon cancer line) were obtained and cultured in DMEM and McCoy’s 5A 
Modified Media, respectively, with 10% FBS, 1% penicillin/streptomycin, and 1% 
glutarate added.  These cell lines were grown directly on eight chambered slides, 
which were then washed with PBS, fixed with a 1:1 methanol:acetone mixture for 
five minutes, air-dried, and washed again in 2xSSC for sixty minutes before being 
stored at 4˚C. 
The T cell lines Jurkat, HSB, HSC, SKW3, SUPT1, HUT78, and HPB-ALL 
were obtained by generous donation from the laboratory of Peter Cresswell. Ph.D., 
Yale University, Department of Immunobiology.  The B cell line Raji was acquired 
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from the laboratory of George Miller, M.D., Yale University, Department of 
Pediatrics.  These clonal lymphocyte lines were cultured in RPMI media with 10% 
FBS, 1% pen/strep, 1% glutarate.  Cell pellets for each cell line were created by 
spinning 32 ml of each culture at 1500 rpm for three minutes, removing the 
supernatant, resuspending in 10 ml PBS, vortexing, centrifuging again at 1500 rpm 
for three minutes, removing the supernatant and resuspending in 10 ml of 10% 
buffered formalin.  After fixing for one hour in formalin, the cultures were 
centrifuged again at 1500 rpm for three minutes, dehydrated with successive 
resuspensions in 10 ml 70%, 95%, and 100% ethanol before finally being 
resuspended in 40 µl Histogel (available at www.labstore.com, No. HG-4000).  These 
cell pellets were cut into 10 µm sections with a microtome and placed on slides by 
Research Histology.   
In the subsequent experiments conducted by Jonathan Murphy, the clonal B 
cell line Namalwa and the clonal T cell line Jurkat were cultured in the same fashion 
as the T cell lines above.  1 ml of the cell lines in RPMI media was centrifuged at 300 
G for five minutes and the pellet was resuspended in 300 µl PBS.  200 µl of this 
suspension was added to a single well of an eight-well poly-D-lysine coated slide.  
The slide was centrifuged for five minutes at 200 G.  The polystyrene vessel was 
removed from the slide, and the slide was submerged in 0.075 M KCl hypotonic 
solution for twelve minutes at 37˚C, followed by submersion in a 70% ethanol 
solution for five minutes.  The slide was allowed to air dry, and was stored at 4 ˚C 
prior to use. 
 
  
26 
Sequential RNA and DNA FISH: 
Only DAPK1 and EBF probes were used for sequential RNA and DNA FISH, which 
was carried out on tonsil, thymus, the Jurkat and HUT78 cell pellets, and the HESC 
and HCT116 glass slides.  All but the HESC and HCT116 glass slides required 
deparaffinization prior to hybridization. 
 
Deparaffinization:  Slides requiring deparaffinization were heated at 56˚C for 2-3 
hours, before being immersed in xylene three times for ten minutes each at room 
temperature.  Two final washes in 100% ethanol for five minutes at a time followed, 
before the slides were allowed to air dry. 
 
Probe Hybridization:  Following deparaffinization, if necessary, slides were 
pretreated in 2xSSC at 37˚C for one hour before immersion in 1:25 dilution of the 
protease Digestall3 (Zymed, now Invitrogen) for five minutes at room temperature.  
After protease digestion, slides were washed in PBS-T for two minutes, then fixed in 
10% buffered formalin for one minute before a second wash in PBS-T for two 
minutes, all at room temperature.  Following this washing, slides underwent 
sequential dehydration in 70%, 95%, and 100% ethanol for two minutes each at room 
temperature, and were allowed to air dry.  At this point, 10 µl of either DAPK1 or 
EBF probe solution, having been denatured previously at 73˚C for five minutes, were 
applied.  A coverslip was sealed on with rubber cement, and the slides were placed on 
a plate heater at 37˚C, where they incubated for fourteen hours to allow RNA 
hybridization to occur.  Following hybridization, the coverslips were removed, and 
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the slides underwent stringency washing in 0.5xSSC at 72˚C two times for five 
minutes each, followed by immersion in PBS-T for two minutes at room temperature.  
They were again fixed in 10% buffered formalin for one minute before a wash in 
PBS-T and sequential dehydration in 70%, 95%, and 100% ethanol for two minutes 
each at room temperature.  Following air-drying, another 10 µl of the same probe 
solution, either EBF or DAPK1, was applied, this time labeled with the opposite 
color, either Spectrum Red or Spectrum Green.  A coverslip was sealed on with 
rubber cement, and this time, the slides were incubated at the denaturation 
temperature of 73˚C on a plate heater for five minutes before incubation for fourteen 
hours at 37˚C to allow DNA hybridization to occur.  A second stringency wash 
followed, with 0.5xSSC at 72˚C two times for five minutes each, followed by 
immersion in PBS-T for two minutes at room temperature.  15 µl of DAPI was added 
to stain the nuclei, a coverslip was applied, and the slides were stored at 4˚C.  
Microscopic examination was performed with an Olympus fluorescence microscope 
having polarized filters able to detect Spectrum Red and Spectrum Green.   
 
DNA FISH Alone: 
For experiments requiring DNA FISH alone, we used the VP 2000 (Abbott 
Molecular No. 02J11-060) slide processor utilized by the Molecular Diagnostics 
Service for clinical FISH assays.  This instrument is calibrated to process formalin-
fixed, paraffin-embedded tissue, so we were able to use slides prepared from tonsil, 
thymus, and the T-cell and B-cell pellets.   Both DAPK1 and EBF (as a control) and 
the TCR beta probes were used.   On the VP 2000 Processor, slides were incubated 
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for sixty minutes at 55˚C, before immersion in xylene three times for ten minutes 
each at room temperature, and in 100% ethanol two times for five minutes each, also 
at room temperature.  Slides then dried for five minutes at 55˚C, and were placed in a 
0.2N HCl bath for fifteen minutes at room temperature.  Next they were washed in a 
water bath for three minutes at room temperature, before immersion in pretreatment 
solution (VP 2000 reagent, Abbott Molecular 30-801250) for thirty minutes at 80˚C.  
Following pretreatment, slides were immersed in protease solution (Abbott Molecular 
30-801255, 0.1 N HCl) for thirty minutes at 37˚C.  They were then washed in 2xSSC 
for five minutes, and finally 70%, 85%, and 100% ethanol for one minute each, all at 
room temperature.  After drying for five minutes at 55˚C, 10 µl of either EBF or 
DAPK1 probes, or a mixture of 7µl VDR probes with 7 µl of either 3CR or 5CR were 
applied to a slide.  A coverslip was placed on the slides, sealed with rubber cement, 
and slides were placed on a plate heater at 73˚C for five minutes before incubating at 
39˚C for sixteen hours.  Following hybridization, the coverslips were removed and 
the slides were placed in posthybridization buffer (67 ml 20xSSC, 547 ml ddH2O, 2 
ml Igepal CA 630) for 120 minutes at 74˚C.  At this point, 10 µl DAPI was added, a 
coverslip was placed on the slides, and the slides were stored at 4˚C until microscopic 
examination. 
In the subsequent experiments conducted by Jonathan Murphy, the probes 
generated by PCR were added to the 8-well slide containing clonal Namalwa or 
Jurkat cells, following the VP2000 protocol as described above.  Following 
hybridization, the coverslips were removed and slides were placed in 0.4XSSC/0.3% 
NP-40 for two minutes at 73˚C, followed by 2XSSC/0.1% NP-40 at room 
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temperature for one minute.  Slides were allowed to air dry for ten minutes at room 
temperature, at which point 10 µl DAPI was added, a coverslip was applied, and the 
slides were stored at 4˚C until microscopic examination. 
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Results 
We tested both methods designed to detect cell clonality in situ, the first to 
assess allelic expression patterns of DAPK1 and EBF, both of which are known to be 
subject to random monallelic gene expression, and the second to assess the status of 
allelic recombination in the T cell receptor beta locus.   
To test the first method, probes corresponding to introns of the DAPK1 and 
EBF genes were hybridized to benign tonsil and thymus tissue as well as to clonal T 
cell pellets and clonal epithelial cells.  These experiments either involved sequential 
RNA and DNA FISH with distinct probes labeled with different fluorophors to 
distinguish DNA from RNA, or involved DNA FISH alone with a single fluorophor.  
The DNA FISH served to identify the two alleles in each cell and provided a control 
for accessibility of each allele for hybridization.  RNA FISH allowed the 
determination of whether a cell expressed DAPK1 or EBF at one or both alleles.  
Only cells containing two distinct DNA FISH hybridization loci and at least one RNA 
FISH hybridization locus could be used for clonal assessment.  Cells not meeting 
these criteria were disregarded.  
Under the experimental conditions used, initial attempts at sequential RNA 
and DNA FISH resulted in no cells that could be counted for clonal assessment.  A 
representative image is shown in Figure 3, which demonstrates DAPI signal 
identifying lymphocyte nuclei, and no appreciable green signal identifying the 
DAPK1-encoding DNA alleles or red signal identifying nascent RNA being 
transcribed at one or both alleles.    
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In view of these results, RNA FISH was set aside, and DNA FISH was 
performed alone on tonsil tissue using the VP 2000 Processor, with green-labeled 
probes to identify the DAPK1 or EBF alleles in separate hybridizations.  These 
hybridizations were more successful.  Representative images are shown in Figures 4 
and 5, which illustrate DNA FISH on tonsil tissue using DAPK1 and EBF probes, 
respectively.  
To test the second method, which involved analysis of recombination in the 
TCR beta gene and required only DNA FISH without RNA FISH, probes 
corresponding to the VDR region between V29-1 and D1 of the TCR beta locus along 
with probes for control regions both 5’ and 3’ of the TCRB locus were hybridized to 
tonsil, thymus, and monoclonal T-cell pellets using the VP 2000 Processor.   The 
VDR probes were labeled with either red or green fluorophor, using a different color 
from the control region probes to distinguish the test signals from the control signals.  
Only cells containing two control region signals identifying the TCR beta locus could 
be used for clonal assessment.  Successful analyses should reveal a VDR signal 
present next to one or neither of the control region signals, depending on whether one 
or both alleles had undergone complete V-DJ rearrangement and lost the region of 
DNA to which the VDR probe should hybridize.   
Under the experimental conditions used, no cells demonstrated VDR signal 
next to a control region signal in a cell containing two control region signals.  Very 
few cells contained two control region signals, and the presence of nonspecific 
background signal rendered most experiment iterations unusable despite stringency 
washings.  A representative image is shown in Figure 6, which is a composite of 
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green, red, and blue filtered images of benign thymus tissue, to which red-labeled 
VDR and green-labeled 3CR probes have been hybridized.  While there are multiple 
red signals, their size and distribution indicates that they most likely represent 
nonspecific background signal instead of true VDR hybridization.  As a comparison, 
Figure 7 is a green-filtered image of thymus tissue to which green-labeled 3CR 
probes have been hybridized.  While there are certainly some larger signals that may 
be non-specific, the presence of several smaller signals, often in pairs, suggests that at 
least some of the green signals reflect true hybridization.  To be sure of this, it would 
be helpful to see at least some cells with red VDR signals, but under these 
experimental conditions none were identified.  
In a subsequent experiment, conducted by Jonathan Murphy, the second 
method was again tested, this time using PCR-generated probes from the 64 kb test 
region between V29-1 and D1 at the TCRB locus and from the 3CR control region.  
The test region probes were labeled green, and the control region probes were labeled 
red.  These probes were hybridized to clonal Namalwa B cells and to clonal Jurkat T 
cells.  Figures 8 and 9 show Namalwa B cells photographed in the fluorescence 
microscope using a red filter and a green filter, respectively.  The red-filtered image 
demonstrated two red signals in most of the Namalwa cells, most likely identifying 
the control regions located just 3’ to the two alleles of the T-cell receptor beta locus.  
The green-filtered image demonstrated two green signals in identical locations, with 
occasional extraneous signals that most likely represent artifact.  The green signals 
that overlap with the red signals identified on the red filter most likely represent true 
hybridization to the T cell receptor beta locus.  The test region is intact at both alleles 
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in these B cells, which have not undergone recombination within the TCRB loci.  By 
comparison, Figures 10 and 11 show Jurkat T cells photographed using a red filter 
and a green filter, respectively.  The red-filtered image again demonstrated two red 
signals in most cells, likely identifying the control region 3’ to the TCRB locus, but 
the green-filtered image demonstrates only one green signal that overlaps with the red 
signals in each cell, along with occasional artifactual signals that do not overlap with 
red signals.  The presence of only one overlapping signal in these T-cells is consistent 
with the fact that one of the TCRB alleles has successfully undergone VDJ 
recombination, and the second allele has not undergone V-DJ joining.  While these 
images represent analyses of only two clonal cell lines, they suggest that the use of 
DNA FISH to determine the status of T cell receptor beta recombination may, with 
additional refinements, be used to assess clonality of T cells in situ. 
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Discussion 
In this thesis, two promising methods of detecting a monoclonal population of 
human cells have been described, although their feasibility and usefulness cannot yet 
be determined as the molecular techniques are still being refined.  The promise of 
both methods relies upon several necessary assumptions, which could not be affirmed 
or rejected in this study.  Unless these assumptions are rejected by subsequent work, 
the clonality assays proposed here have the potential to become valuable clinical tools 
to aid in the diagnosis of malignancy, or at the very least useful methods for studying 
malignant transformation and preneoplastic lesions.    
Potential pitfalls to the use of random monoallelic gene expression as an assay 
for monoclonality would include the finding that this phenomenon occurs in too few 
cells within a tissue, that the phenomenon is limited to only a small set of tissues, that 
the progeny of a dividing cell do not retain the same pattern of allelic inactivation, or 
that even a single cell can change its pattern of allelic inactivation during its lifetime.  
While any of these pitfalls could turn out to be real, the experiments described in this 
thesis did not fail because of any of them. 
Similarly, using FISH to analyze T cell receptor gene rearrangement as an 
assay for clonality of T cell populations would be problematic if the ratio of human T 
cells with rearrangements of one TCR beta allele to those with rearrangements of 
both is either too small or too large to allow statistically significant analysis of 
variations within cell populations, or that a cell with only one allelic rearrangement 
early in its development can frequently undergo a second rearrangement during its 
later life.   The experiments described in this thesis found no evidence to suggest that 
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these problems applied, but neither did they rule out the possibility of these problems 
potentially complicating the assay. 
The inability of this experiment to support or reject the necessary assumptions 
underlying both proposed methods relies solely on the failure of our experimental 
technique.  In further experiments, we will attempt to increase the sensitivity and 
specificity of the hybridization assays by pursuing one or several of the following 
methods.  First, the use of BAC clones as sources of probe, while successful in the 
Gimelbrant et al. study, may result in the labeling of too much bacterial DNA and not 
enough target human DNA to cause enough specific hybridization versus nonspecific 
binding of probe.  Instead, we can either purify the BAC DNA away from bacterial 
genomic DNA, subclone it, or use pooled, labeled PCR products as probes that 
specifically target the test regions.  The resulting reduction of background signal may 
allow more successful visualization of true hybridization.  As described in the Results 
section, our initial experiments with pooled, labeled PCR products have already been 
very promising.  Additionally, the fluorophors we used may not be bright enough to 
be visible when hybridized to such short DNA regions as the VDR probe, which is 
only 16 kb long.  Using so-called indirectly-labeled probes rather than probes directly 
labeled with fluorescent tags would allow the use of signal amplification steps to 
increase the signal of the shorter regions and allow better visualization under the 
microscope.   For example, biotin-conjugated nucleotides incorporated into the probes 
can be detected by incubating the hybridized probe with FITC-avidin, followed by 
biotinylated anti-avidin, and a final round of FITC-avidin (65).  One or several of 
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these methods may improve the assays so that we can assess clonality on a routine 
basis. 
One of the more immediate areas where either method of in situ clonality 
analysis would be useful is for very small biopsy specimens in which there are few 
cells available for analysis.  As the use of minimally invasive biopsy techniques 
become more prevalent and biopsy samples become smaller, the challenge of 
diagnosis on low numbers of cells has grown.  Additionally, some neoplastic 
disorders contain very few neoplastic cells, the bulk of the mass in these tumors being 
made up of tissue reacting to the presence of the neoplastic cells.  Hodgkin’s disease 
is an example of such a disorder, in that the neoplastic Reed-Sternberg cell usually 
makes up less than one percent of the cells in the mass.  Finally, certain cancers are 
being identified at earlier and earlier stages, when the total number of malignant cells 
may be quite low. 
A disease that illustrates all of the above diagnostic problems and for which in 
situ analysis of clonality would be very useful is the assessment and diagnosis of 
cutaneous T-cell lymphoma (CTCL).   CTCL is a relatively rare malignancy, with an 
estimated annual incidence of 1:100,000; treatment options are limited and prognosis 
is often poor, depending upon the particular type (72).   The diagnosis is often 
difficult, relying primarily on histologic and immunophenotypic features that can be 
difficult to distinguish from reactive lymphocytic responses, such as chronic 
dermatoses, which are quite common (12, 13).  Because of the difficulty in making 
the distinction between CTCL and chronic dermatoses, the actual number of skin 
biopsy specimens for which CTCL enters the differential diagnoses is very high.  As 
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the amount of tissue available for examination is often very small, an in situ assay 
that could distinguish a reactive process from a monoclonal proliferation would be 
valuable to clinicians and researchers.  To this end, in 2003 Magro et al. published 
their work using in situ RT-PCR to examine the TCR beta rearrangement patterns, 
with primers distinguishing the 25 possible V region recombinations (26).  They 
examined the tissue of 28 patients with cutaneous T-cell infiltrates including benign 
lesions as well as CTCL, diagnosed by clinical, histologic, and immunophenotypic 
analysis.   Of the eight cases of primary CTCL lymphoma, seven were identified as 
monoclonal by in situ RT-PCR, while the other case was found to be “biclonal.”   
As discussed earlier, there are several limitations to the potential for clinical 
adoption of in situ RT-PCR as currently performed-–limitations that a DNA FISH-
based assay would overcome.  The amount of tissue required for DNA FISH is much 
less, and DNA FISH does not require sequential iterations to distinguish the 25 
possible V-DJ rearrangements.  However, the DNA FISH-based assay as we have 
described it could not identify the particular VDJ rearrangement of a monoclonal 
population, as the RT in situ PCR-based assay can.  Nevertheless, this property is 
probably not necessary for a useful assay of clonality in T cell disorders.  This 
opinion is based on the diagnostic utility of immunohistochemical detection of 
restricted kappa versus lambda light chain immunoglobulin associated with 
monoclonal B cell processes.  Therefore, if our proposed assay for clonal TCR beta 
gene rearrangements can be performed successfully, it could facilitate clinical 
examination of cutaneous T cell proliferations with the possibility of emerging as an 
important diagnostic assay.  In the long run, if the in situ assay using random 
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monoallelic gene expression can be perfected, this too would be applicable to 
cutaneous T cell disorders.   
We conclude that although limits of time prevented the full development of 
the in situ assays to identify clonality proposed here, both have the potential to 
become valuable tools in research and clinical practice.  They certainly merit further 
investigation.  
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Figures: 
 
Figure 1.  
 
 
 
BAC Clone Verification: 2% agarose gel electrophoresis with PCR products of BAC 
clone DNA using probes complementary to DAPK1 and EBF sequences.  Lane 1, 1 
kb ladder of size markers.  Lanes 2-6, PCR products of DNA extracted from BAC 
clone RP11-107G16 with primers targeting DAPK1 reveals ~3.5kb product, with a 
water control in Lane 6. Lane 7, blank. Lanes 8-11, PCR products of DNA extracted 
from BAC clone RP11-155P16 with primers targeting EBF reveals ~3.3kb product, 
with a water control in Lane 11.  
 
Figure 2.  
 
 
 
BAC Clone Verification, cont’d: Composite 2% agarose gel electrophoresis of PCR 
products of BAC clone DNA using probes complementary to VDR, 3CR, and 5CR 
sequences.  Lane 1, 100 bp ladder.  Lane 2, blank. Lanes 3-6, PCR products of DNA 
extracted from BAC clone CTD-3217E23 with primers targeting VDR reveals ~300 
bp product, with a water control in Lane 3.  Lanes 7-10, PCR products of DNA 
extracted from BAC clone RP11-368I15 with primers targeting 3CR reveals ~250 bp 
  
46 
product, with a water control in Lane 7.  Lanes 11-14, PCR products of DNA 
extracted from BAC clone RP11-10L5 with primers targeting 5CR reveals ~250 bp 
product, with a water control in Lane 11.  
 
Figure 3.  
 
 
 
DAPK1 Sequential RNA and DNA FISH: Representative composite image of blue-, 
red-, and green-filtered microscopy of a section from a monoclonal HSB T cell pellet 
hybridized first to red-labeled DAPK1 probe in RNA FISH, followed by green-
labeled DAPK1 probe in DNA FISH.  Nuclei have been stained blue with DAPI, 
which binds to DNA and therefore marks the entire nucleus of interphase cells.  
Neither red nor green signals are visible, suggesting that little, if any hybridization 
had occurred.  A significant amount of nonspecific and non-nuclear red and green 
signal was present, not visible in this image.   The only signals suggestive of true 
hybridization occurred with DNA FISH using the VP 2000 processor, and not with 
sequential RNA and DNA FISH (see below). (x600 magnification) 
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Figure 4.  
 
 
 
DAPK1 DNA FISH Control: Green-filter microscopy of benign tonsil tissue 
hybridized to DAPK1 probes in DNA FISH using the VP 2000 processor.  Multiple 
cells display two green signals suggestive of bone fide hybridization, although 
simultaneous RNA FISH would help to confirm this.  The extent of hybridization is 
better determined by direct inspection under the microscope, rather than in 
photographs, because of the hybridization signals lying in several focal plains. (x600 
magnification) 
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Figure 5.  
 
 
 
EBF DNA FISH Control: Green-filter microscopy of benign tonsil tissue hybridized 
to EBF probes in DNA FISH using the VP 2000 processor.  Again, multiple cells 
display two green signals suggesting bona fide hybridization. (x600 magnification) 
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Figure 6.  
 
 
 
TCR Beta DNA FISH: Composite image of blue-, green-, and red-filtered microscopy 
of benign thymus tissue hybridized to red-labeled VDR probes and green-labeled 
3CR probes by DNA FISH on the VP 2000 processor.   Multiple red signals are 
present, but the lack of cells with two green (control) signals and the large size of 
several of the red signals indicate that these signals are unlikely to represent true 
hybridization.     
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Figure 7.  
 
 
 
3CR DNA FISH Control: By comparison, green-filtered microscopy of benign 
thymus tissue hybridized to green-labeled 3CR probe in DNA FISH on the VP 2000 
processor indicates smaller signals, often with two signals in a cell, more suggestive 
of true hybridization than the red signals in Figure 6.  However, most cells contain no 
green signals or obviously nonspecific signal (large, bright spots).   
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Figure 8.  
 
 
 
 
B Cell TCR beta DNA FISH Control: Red-filter microscopy of clonal Namalwa B 
cells hybridized to pooled PCR-generated probes targeting the 3CR region, in DNA 
FISH performed with the VP 2000 processor.  Multiple cells display two red signals 
suggestive of bona fide hybridization.  This experiment was conducted by Jonathan 
Murphy. 
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Figure 9. 
 
 
 
B Cell TCR beta DNA FISH: Green-filtered photograph of the same microscopic 
view as Figure 8.  Green-labeled PCR-generated probes specific to the 64 kb VDR 
test region deleted in successful V-DJ recombination have been hybridized to clonal 
Namalwa B-cells in DNA FISH.  Again, multiple cells display two green signals 
suggestive of bona fide hybridization to the TCRB test region, with occasional 
artifactual signals. 
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Figure 10. 
 
 
 
T Cell TCR beta DNA FISH Control: Red-filter microscopy of clonal Jurkat T cells 
hybridized to pooled PCR-generated probes specific for the 3CR region, in DNA 
FISH performed with the VP 2000 processor.  Multiple cells display two red signals 
likely indicating the control region adjacent to the TCRB locus.  This experiment was 
conducted by Jonathan Murphy. 
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Figure 11. 
 
 
 
 
T Cell TCR beta DNA FISH: Green-filtered photograph of same microscopic view as 
in Figure 10.  Green-labeled pooled PCR probes targeting the test region between 
V29-1 and D1 have been hybridized to clonal Jurkat T-cells in DNA FISH performed 
with the VP2000 processor.  Most cells have a single green signal overlapping one of 
the two red signals in Figure 10, suggestive of a single non-rearranged TCRB allele.  
The other green signals most likely represent artifact.  
 
